Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 4/20 | 0.56 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.52 |
| ▸ | F7 | P08709 | 1/20 | 0.50 |
| ▸ | F3 | P13726 | 1/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27879386 | 0.97 | NR4A2 (0.54) | NR4A2SOS2F7F3DYRK1A | |
| Bromide SCHEMBL11411808 | 0.97 | NR4A2 (0.54) | NR4A2SOS2F7F3DYRK1A | |
| SCHEMBL14919991 | 0.75 | PIM1 (0.50) | HTTNPC1RAB9AKMT2AMEN1 | |
| SCHEMBL9257557 | 0.73 | HRH4 (0.47) | NR4A2F7F3DYRK1AHTT | |
| SCHEMBL5157381 | 0.72 | PIK3CG (0.58) | NR4A2F7F3DYRK1AKMT2A | |
| SCHEMBL8337311 | 0.72 | NPC1 (0.52) | DYRK1ANPC1RAB9AKMT2AMEN1 | |
| SCHEMBL31061987 | 0.72 | NR4A2 (0.53) | NR4A2SOS2HTTNPC1RAB9A | |
| SCHEMBL8401811 | 0.72 | PIK3CG (0.47) | NR4A2SOS2F7F3DYRK1A | |
| SCHEMBL29393522 | 0.72 | NR4A2 (1.00) | NR4A2SOS2HTTNPC1RAB9A | |
| SCHEMBL317870 | 0.72 | NR4A2 (1.00) | NR4A2SOS2HTTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4168401-B1 | SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2026-01-07 | — | — | EP | claimed |
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20230227429-A1 | SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2023-07-20 | — | — | US | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| CN-104513234-A | Synthesis method for high-quality quizalofop-P-tefuryl | JIANGSU TIANRONG GROUP CO LTD | 2015-04-15 | — | — | CN | claimed |
| CN-102584803-A | Preparation method of high-content quizalofop-P-tefuryl | Jiangsu fengshan group co ltd | 2012-07-18 | — | — | CN | claimed |
| CN-121931199-A | Method for synthesizing quinoxaline and derivative thereof by using chemical enzyme synergistic catalytic system | 南京工业大学 | 2026-04-28 | — | — | CN | disclosed |
| CN-119822910-A | Method for catalyzing heterogeneous reduction of nitrogen-containing heterocyclic compound by using magnesium metal | 延安大学 | 2025-04-15 | — | — | CN | disclosed |
| CN-118546099-A | Production method of low-sulfur impurity 2, 6-dichloro quinoxaline | 濮阳市旌胜新能源科技有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-118027042-A | Organic electroluminescent compound and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-111094508-B | Organic electroluminescent compound and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117143018-A | Synthesis method of rare earth catalytic nitrogen-containing heterocyclic compound | 温州大学新材料与产业技术研究院 | 2023-12-01 | — | — | CN | disclosed |
| CN-1017994-B | Process for producing 2-quinoxalinol | UNIROYAL CHEM CO INC (US) | 1992-08-26 | — | — | CN | disclosed |
| CN-1060008-A | The 4-Quinoxalinyloxy pheroxyalkylnitrile herbicides | UNIROYAL CHEM CO INC (US) | 1992-04-08 | — | — | CN | disclosed |
| CN-1035505-A | Heterocyclic-alkylene quinoxalinyloxyphenoherbicideste herbicideste | UNIROYAL CHEM CO INC (US) | 1989-09-13 | — | — | CN | disclosed |
| CN-1030915-A | The process for selective reduction of 2-quinoxaline-4-oxide compound | UNIROYAL CHEM CO INC (US) | 1989-02-08 | — | — | CN | disclosed |
| CN-1030914-A | The production method of 2-quinoxaline | UNIROYAL CHEM CO INC (US) | 1989-02-08 | — | — | CN | disclosed |
| CN-87103559-A | Macrolide compounds, their production and use | — | 1988-01-27 | — | — | CN | disclosed |
| EP-0042750-A2 | Quinoxalinyloxy ethers as selective weed control agents | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227429-A1 | SULPHONAMIDE COMPOUNDS | MLKL, RIPK3, CASP1 | NR4A2 4383/4885SOS2 599/4885F7 3770/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | NR4A2 3035/4885SOS2 18/4885F7 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.